02:09:57 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Aurinia Pharmaceuticals Inc
Symbol AUP
Shares Issued 85,500,228
Close 2019-02-26 C$ 9.19
Market Cap C$ 785,747,095
Recent Sedar Documents

Aurinia closes $30-million (U.S.) in ATM offerings

2019-02-27 07:54 ET - News Release

Mr. Glenn Schulman reports

AURINIA CLOSES AT-THE-MARKET FACILITY

Further to its open market sale agreement with Jefferies LLC previously disclosed on Nov. 30, 2018, in relation to at-the-market (ATM) offerings of common shares in the capital of the company, Aurinia Pharmaceuticals Inc. has completed the sale of 4,608,409 common shares at a weighted average price of $6.55 (U.S.) for aggregate gross proceeds of approximately $30-million (U.S.). No further sales will be conducted pursuant to the ATM.

About Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals is a clinical late-stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations impacted by serious diseases with a high unmet medical need.

© 2024 Canjex Publishing Ltd. All rights reserved.